174 related articles for article (PubMed ID: 35050428)
21. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
Front Immunol; 2021; 12():653786. PubMed ID: 33981305
[TBL] [Abstract][Full Text] [Related]
22. Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis.
Castaldo M; Waliszewska-Prosół M; Koutsokera M; Robotti M; Straburzyński M; Apostolakopoulou L; Capizzi M; Çibuku O; Ambat FDF; Frattale I; Gadzhieva Z; Gallo E; Gryglas-Dworak A; Halili G; Jusupova A; Koperskaya Y; Leheste AR; Manzo ML; Marcinnò A; Marino A; Mikulenka P; Ong BE; Polat B; Popovic Z; Rivera-Mancilla E; Roceanu AM; Rollo E; Romozzi M; Ruscitto C; Scotto di Clemente F; Strauss S; Taranta V; Terhart M; Tychenko I; Vigneri S; Misiak B; Martelletti P; Raggi A;
J Headache Pain; 2022 Mar; 23(1):41. PubMed ID: 35361131
[TBL] [Abstract][Full Text] [Related]
23. Case Report: Acquired Haemophilia A Following mRNA-1273 Booster Vaccination Against SARS-CoV-2 With Concurrent Diagnosis of Pleomorphic Dermal Sarcoma.
Plüß M; Mitteldorf C; Szuszies CJ; Tampe B
Front Immunol; 2022; 13():868133. PubMed ID: 35479071
[TBL] [Abstract][Full Text] [Related]
24. Pituitary apoplexy and COVID-19 vaccination: a case report and literature review.
Aliberti L; Gagliardi I; Rizzo R; Bortolotti D; Schiuma G; Franceschetti P; Gafà R; Borgatti L; Cavallo MA; Zatelli MC; Ambrosio MR
Front Endocrinol (Lausanne); 2022; 13():1035482. PubMed ID: 36465651
[TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review.
Afshar ZM; Barary M; Babazadeh A; Hosseinzadeh R; Alijanpour A; Miri SR; Sio TT; Sullman MJM; Carson-Chahhoud K; Langer F; Ebrahimpour S
Rev Med Virol; 2022 Jul; 32(4):e2327. PubMed ID: 35112763
[TBL] [Abstract][Full Text] [Related]
27. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
[TBL] [Abstract][Full Text] [Related]
28. Inactivated COVID-19 vaccine induced acute stroke-like focal neurologic symptoms: a case series.
Roongpiboonsopit D; Nithisathienchai C; Akarathanawat W; Lertutsahakul K; Tantivattana J; Viswanathan A; Suwanwela NC
BMC Neurol; 2022 Jun; 22(1):210. PubMed ID: 35672709
[TBL] [Abstract][Full Text] [Related]
29. Acute encephalitis after COVID-19 vaccination: A case report and literature review.
Gao JJ; Tseng HP; Lin CL; Hsu RF; Lee MH; Liu CH
Hum Vaccin Immunother; 2022 Nov; 18(5):2082206. PubMed ID: 35700455
[TBL] [Abstract][Full Text] [Related]
30. Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report.
Werner J; Reichen I; Huber M; Abela IA; Weller M; Jelcic I
BMC Infect Dis; 2021 Mar; 21(1):298. PubMed ID: 33761897
[TBL] [Abstract][Full Text] [Related]
31. Anaphylaxis is a rare reaction in COVID-19 vaccination.
Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 vaccination associated venous sinus thrombosis in three patients.
Finsterer J
J Appl Biomed; 2022 Oct; 20(3):83-86. PubMed ID: 36218128
[TBL] [Abstract][Full Text] [Related]
33. Increased risk of functional neurological disorders following SARS-CoV-2 vaccination.
Pilotto A; Catania M; Mattioli I; Zoppi N; Ceccardi G; Rao R; Gipponi S; Magoni M; Gamba M; Padovani A
Eur J Neurol; 2024 Apr; 31(4):e16191. PubMed ID: 38165067
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 mRNA Vaccination and Graves' Disease: A Report of 12 Cases and Review of the Literature.
Chee YJ; Liew H; Hoi WH; Lee Y; Lim B; Chin HX; Lai RTR; Koh Y; Tham M; Seow CJ; Quek ZH; Chen AW; Quek TPL; Tan AWK; Dalan R
J Clin Endocrinol Metab; 2022 May; 107(6):e2324-e2330. PubMed ID: 35235663
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjögren syndrome.
Inanc N; Kostov B; Priori R; Flores-Chavez A; Carubbi F; Szántó A; Valim V; Bootsma H; Praprotnik S; Fernandes Moça Trevisani V; Hernández-Molina G; Hofauer B; Pasoto SG; López-Dupla M; Bartoloni E; Rischmueller M; Devauchelle-Pensec V; Abacar K; Giardina F; Alunno A; Fanny Horváth I; de Wolff L; Caldas L; Retamozo S; Ramos-Casals M; Brito-Zerón P;
Clin Exp Rheumatol; 2022 Dec; 40(12):2290-2297. PubMed ID: 36441656
[TBL] [Abstract][Full Text] [Related]
36. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
37. Silent thyroiditis following vaccination against COVID-19: report of two cases.
Capezzone M; Tosti-Balducci M; Morabito EM; Caldarelli GP; Sagnella A; Cantara S; Alessandri M; Castagna MG
J Endocrinol Invest; 2022 May; 45(5):1079-1083. PubMed ID: 35034341
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].
Poh XY; Lee IR; Lim C; Teo J; Rao S; Chia PY; Ong SWX; Lee TH; Lin RJH; Ng LFP; Ren EC; Lin RTP; Wang LF; Renia L; Lye DC; Young BE
Trials; 2022 Jun; 23(1):498. PubMed ID: 35710572
[TBL] [Abstract][Full Text] [Related]
39. Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection.
Simon HU; Karaulov AV; Bachmann MF
Int Arch Allergy Immunol; 2020; 181(8):624-628. PubMed ID: 32544911
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache.
Martelletti P
Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36900925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
